15 January
On
In Press Releases
Tagged , , , , , , , , ,

New study from Voy shows that patients taking a GLP-1 drug who engaged with coaching sessions and app-based support over the course of 12 months achieved a 30% higher relative body weight loss compared to those using medication alone. (London, January 15, 2026) Voy, the digital health provider, has announced the publication of a new study in the Journal of Medical Internet Research analyzing the efficacy of a GLP-1 drug for achieving weight loss results in patients who engage regularly with a supporting coaching program compared to patients who rely on the medication alone. The large-scale study examined the progress of over 126,000 UK-based Voy patientsRead More →

Overweight Woman With Digital Tablet Checking Calorie Intake. Source: Shutterstock; Copyright: Monkey Business Images; License: Licensed by the authors
29 July
On
In Press Releases
Tagged , , , , , , , , ,

JMIR Publications recently published “A 12-Month Follow-Up of the Effects of a Digital Diabetes Prevention Program (VP Transform for Prediabetes) on Weight and Physical Activity Among Adults With Prediabetes: Secondary Analysis” in JMIR Diabetes which reported that previous research has demonstrated the efficacy of a diabetes prevention program (DPP) in lifestyle modifications that can prevent or delay the onset of type 2 diabetes among individuals at risk. The aim of this study is to investigate the effects of a digital DPP on weight and physical activity among participants who had completed 12 months of the program. This study was also a secondary analysis of retrospectiveRead More →